Jun 13,2019

Cleveland Clinic study finds Propeller Health platform helps reduce hospitalizations among COPD patients

New research from Cleveland Clinic found the use of electronic inhaler monitoring combined with a disease management program reduced healthcare utilization in patients with chronic obstructive pulmonary disease. All patients received electronic monitoring devices and rescue inhalers. Digital therapeutics company Propeller Health provided the monitoring platform, which connects a sensor to the patient’s existing inhaler. The results show that when compared to the year before enrollment, patients experienced a reduction in COPD-related healthcare utilization, as the average number of trips to the hospital went from 3.4 to 2.2.

CLINICAL STUDY

#mobile app

#connected device

View Analyst & Ambassador Comments
Go to original news
Aug 12,2019

DarioHealth® Clinical Study Data Shows the Dario Membership Program Assists Diabetes Patients in Achieving Pre-Diabetic Blood-Glucose Levels and Consistent In-Range Measurements

DarioHealth, a leading global, digital therapeutics company, presented new clinical data yesterday at the American Association of Diabetes Educators ("AADE") conference in Houston, Texas, which showed remarkable improvements in average blood-glucose levels and in-range measurements in patients with diabetes using Dario's digital therapeutics platform and dedicated one-on-one personal health coaching. The Dario study was based on the analysis of clinical data of 162 Dario users. In order to establish a baseline blood-glucose level prior to commencement of the study, the Dario users study group consistently measured their blood-glucose levels one month prior to starting the Dario personal coaching program. In the results of the study, 45% (73 out of 162) of the study group reduced their average blood-glucose levels to under 140 mg/dL, which is considered a pre-diabetic measurement according to ADA guidelines

CLINICAL STUDY

#mobile app

#coaching

View Analyst & Ambassador Comments
Go to original news
Jan 03,2019

Pilot study: Akili's digital ADHD therapy feasible, well liked by autistic children, parents

A small feasibility study conducted by the Children’s Hospital of Philadelphia suggests that Project: Evo, the digital medicine developed by Akili Interactive Labs that is delivered via a video game, continually engaged children with autism spectrum disorder (ASD) and reduced their ADHD symptoms, although more objective measures of cognitive control were mixed.

CLINICAL STUDY

#software

View Analyst & Ambassador Comments
Go to original news
Oct 09,2019

Estimating the Impact of Novel Digital Therapeutics in Type 2 Diabetes and Hypertension: Health Economic Analysis

Behavioral interventions can meaningfully improve cardiometabolic conditions. Digital therapeutics (DTxs) delivering these interventions may provide benefits comparable to pharmacologic therapies, displacing medications for some patients. Our objective was to estimate the economic impact of a digital behavioral intervention in type 2 diabetes mellitus (T2DM) and hypertension (HTN) and estimate the impact of clinical inertia on deprescribing medications.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Jan 24,2019

Real-World Data based on Kaiku Health Immune Checkpoint Inhibitor Module published in Journal of Cancer Research and Clinical Oncology

Kaiku Health, Oulu University Hospital and Docrates Cancer Center have published first data on the symptoms reported by cancer patients receiving immune checkpoint inhibitor (ICI) therapies in a real-world setting. The purpose of the study was to investigate whether symptoms reported by cancer patients using the Kaiku Health ICI module corresponded to symptoms reported in earlier clinical trials. The study also sought to investigate the feasibility of electronic self-reporting of symptoms and whether there are significant correlations between different reported symptoms.

CLINICAL STUDY

#rpm

#software

View Analyst & Ambassador Comments
Go to original news
Dec 12,2019

Research shows that machine learning can be used to predict the onset and continuity of symptoms on patients receiving immune checkpoint inhibitor therapies

The results indicate that machine learning-based modeling of patient-reported symptom data on ICI treated cancer patients can predict the onset and continuity of symptoms related to ICI toxicities. The best performance considering all metrics was found for shortness of breath, joint pain, cough and fatigue. Importantly, all 14 symptom prediction models performed at a good level.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 06,2019

Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical Trial

Studies on long-term sustainability of low-carbohydrate approaches to treat diabetes are limited. It was previously reported the effectiveness of a novel digitally-monitored continuous care intervention (CCI) including nutritional ketosis in improving weight, glycemic outcomes, lipid, and liver marker changes at 1 year. Here, the research assesses the effects of the CCI at 2 years.

CLINICAL STUDY

#coaching

View Analyst & Ambassador Comments
Go to original news
Jul 16,2018

Results of the eCO trial published in the Journal of Clinical Oncology Informatics

The study, published as “Technology APPlications: Use of digital health technology to enable drug development,” examined the feasibility, usability and perceived satisfaction with eCO (eCediranib-Olaparib), a mobile application for side effect monitoring and reporting, in women with recurrent ovarian cancer. The eCO app was specifically designed to assist in managing acute treatment-related events such as hypertension and diarrhea, which are most often associated with treatment discontinuation, the need for drug holidays or dose interruptions/modifications. Survey analysis showed that patients had statistically significant, positive responses to the use of the eCO application.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Aug 20,2018

Small study links behavioral, neural changes in ADHD boys receiving video game intervention

Conducted in Singapore, the study was conducted as part of a larger controlled investigation of boys with ADHD. It compared an intervention group of 18 participants (mean age 9 years) to a control arm of 11 participants (mean age 9.45 years). The former received eight weeks of treatment with a brain computer interface (BCI) therapy delivered using a headband with mounted dry EEG sensors and the ATENTIVmynd video game, an ADHD therapy in which players’ brainwaves and focus levels impact their success. The researchers found that children in the intervention group had significantly more efficient local processing within an area of the brain previously shown to impact how an individual detects the importance of incoming information. The researchers did note some limitations with their investigation, such as the small sample size and the resulting need to combine multiple ADHD subtypes within a single study group.

CLINICAL STUDY

#connected device

#software

View Analyst & Ambassador Comments
Go to original news
Aug 27,2018

Cognoa Demonstrates Advances of its AI-Based Technology for Identifying Autism in Children

Cognoa, a digital behavioral health company, today announces results from a clinical study of its second-generation AI based algorithms which demonstrates accuracy improvements over its first-generation screening algorithm in supporting the diagnosis of autism spectrum disorder (ASD) in young children. Two algorithms are trained to identify autism, one based on short, structured parent-reported questionnaires and the other on tagging key behaviors from short, semi-structured home videos of children. A combination algorithm is then used to combine the results into a single assessment of higher accuracy. A multi-center clinical study of n = 162 children is performed to ascertain the performance of these algorithms and their combination.

CLINICAL STUDY

#software

View Analyst & Ambassador Comments
Go to original news
Subscribe to CLINICAL STUDY